FDA Submits Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in order to improve transparency and communication for new molecular entity new drug applications and original biologics license applications in prescription drug user fee submissions.